Results 291 to 300 of about 708,008 (375)
Nanogel‐Mediated Immunotherapy to Tackle Cancer and Inflammatory Diseases
Nanogels formed through self‐assembly, microemulsion, or precipitation polymerization method enable precise delivery of immunotherapeutic factors and immune cell targeting, thus effectively modulating immune responses. This review highlights recent advances in stimuli‐responsive nanogel design, underlying mechanisms, and their potentials to tackle ...
Ziwen Zhang +7 more
wiley +1 more source
Radiographic Severity and Clinical Implications of Knee Osteoarthritis in Adults Under 55: Incidence and Insight Into Potential Candidates for Geniculate Artery Embolisation. [PDF]
Solomon DJ, McLoughlin P.
europepmc +1 more source
Osteoarthritis: a disease of the joint as an organ.
R. Loeser +3 more
semanticscholar +1 more source
Two macromolecular ester prodrugs of a COX‐2 inhibitor are designed and synthesized. They are based on two different oligo(ethylene glycol) spacers linking the COX‐2 inhibitor to hyaluronic acid. The spacers are designed to differ in the sensitivity to the hydrolytic conditions.
Mario Saletti +13 more
wiley +1 more source
Analysis of key genes and pathways of knee osteoarthritis based on GEO data mining. [PDF]
Gao Y.
europepmc +1 more source
Classifications in Brief: Kellgren-Lawrence Classification of Osteoarthritis
Mark D Kohn +2 more
semanticscholar +1 more source
Nonsteroidal anti‐inflammatory drugs (NSAIDs) are widely used for pain and inflammation but are associated with gastrointestinal (GI) bleeding. While this risk is well established, most studies evaluate NSAIDs as a homogenous class, limiting clinical decision‐making based on individual agent safety.
Abdelrahman G. Tawfik +7 more
wiley +1 more source
Exploring the therapeutic potential of epsom salt bath on pain and intensity of knee osteoarthritis: Randomized controlled trial. [PDF]
Kumar V +5 more
europepmc +1 more source
Abstract Trichorhinophalangeal syndrome (TRPS) is a rare genetic disease inherited in an autosomal dominant manner. It occurs in 1 in 100,000 people globally and is caused by several types of mutations of the TRPS1 gene. Since the first human patient was reported in 1966, typical and atypical pathologies, disease courses, and treatment case ...
Naoya Saeki +6 more
wiley +1 more source

